Related Experiment Video
Updated: Apr 29, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma
Yanping Wei1, Yuwen Du, Xiaonan Chen
1Department of Dermatology, The People's Hospital of Jiaozuo City, Jiaozuo, 454000, Henan, China.
Abstract:
Melanoma is the most aggressive skin cancer, and it is typically resistant or rapidly develops resistance to a variety of chemotherapeutic agents. microRNAs (miRNAs) play a part in the occurrence and development of malignant melanoma. In this study, we analyzed the miR-218 expression level in melanoma patients and cell lines and observed alterations in proliferation, cell cycle, migration, and invasion by increasing miR-218 expression in melanoma cell lines. We also performed bioinformatic analyses using TargetScan and miRanda and cloned both the wild-type and mutant versions of the human cancerous inhibitor of protein phosphatase 2A (CIP2A) and B lymphoma Mo-MLV insertion region 1 (BMI1) 3'-UTR fragments into the pmirGLO reporter vector. We then used the Dual-Luciferase assay system, quantitative real-time RT-PCR (qRT-PCR), and Western blot analysis to determine that miR-218 targeted the 3'-UTR of the oncogenes CIP2A and BMI1 and thus regulated the biological process of melanoma. We further demonstrated that CIP2A and BMI1 knockdown phenocopies miR-218 overexpression. In conclusion, our findings have shown that miR-218 is downregulated in melanoma. By targeting CIP2A and BMI1, miR-218 regulates the proliferation, migration, and invasion of the melanoma cell lines A375 and SK-MEL-2, indicating that miR-218 plays a pivotal role in melanoma development.
Insights
MicroRNAs (miRNAs), specifically miR-218, are downregulated in melanoma. This microRNA targets oncogenes CIP2A and BMI1, regulating melanoma cell proliferation, migration, and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma is an aggressive skin cancer known for its resistance to chemotherapy.
- MicroRNAs (miRNAs) are implicated in the development and progression of malignant melanoma.
- Understanding miRNA roles is crucial for developing novel melanoma therapies.
Purpose of the Study:
- To investigate the expression level and function of miR-218 in melanoma.
- To identify the direct targets of miR-218 in melanoma cells.
- To elucidate the role of miR-218 in regulating melanoma cell biological processes.
Main Methods:
- Analysis of miR-218 expression in melanoma patients and cell lines.
- Bioinformatic analysis using TargetScan and miRanda.
- Dual-Luciferase reporter assays, qRT-PCR, and Western blot to validate miR-218 targets.
- Functional assays assessing proliferation, cell cycle, migration, and invasion.
Main Results:
- miR-218 expression was found to be downregulated in melanoma.
- miR-218 was confirmed to directly target the 3'-UTR of oncogenes CIP2A and BMI1.
- Overexpression of miR-218 inhibited melanoma cell proliferation, migration, and invasion.
- Knockdown of CIP2A and BMI1 mimicked the effects of miR-218 overexpression.
Conclusions:
- miR-218 acts as a tumor suppressor in melanoma by targeting CIP2A and BMI1.
- Restoring miR-218 levels could be a potential therapeutic strategy for melanoma.
- This study highlights the critical role of miR-218 in melanoma pathogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

